John Bernat
Clinical Genetics (M.D.) · Iowa City, IANPI 1609003011
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Chiesi USA, Inc. at 47.3% of the total.
Across 66 payments — averaging $678.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Chiesi USA, Inc.$21K
- Shire North American Group Inc$10K
- Sanofi$6K
- Mirum Pharmaceuticals, Inc.$6K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Ultragenyx Pharmaceutical Inc.$30
Across 473 payments — averaging $4723.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$1.2M
- Chiesi USA, Inc.$537K
- Sanofi US Services Inc.$221K
- Sanofi$127K
- Travere Therapeutics, Inc.$114K
- Biomarin Pharmaceutical Inc.$20K
- plus $36K from 2 others
What the payments were for
- Consulting fees$25,29256%
- Speaking & faculty fees$4,60010%
- Travel & lodging$13,01629%
- Food & beverage$1,8584%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Chiesi USA, Inc. | 24 | $21,172 |
| Shire North American Group Inc | 13 | $9,789 |
| Sanofi | 20 | $6,288 |
| Mirum Pharmaceuticals, Inc. | 7 | $5,918 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,600 |
| Ultragenyx Pharmaceutical Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELFABRIO$14,935
- VPRIV$6,160
- Livmarli$5,668
- CERDELGA$5,076
- NO PRODUCT DISCUSSED$569
How this compares
Too few clinical genetics (m.d.) providers in Iowato place this figure against a meaningful peer group, so we don't.
Other clinical genetics (m.d.) in Iowa City
- Alpa SidhuIowa City$2K
- Amy CalhounIowa City$47
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.